BVT Knock-Out NCB/ DE000VD2G4X0 /
5/29/2024 11:46:20 AM | Chg.+0.025 | Bid1:10:40 PM | Ask1:10:40 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.205EUR | +13.89% | 0.215 Bid Size: 21,000 |
- Ask Size: - |
BANK AMERICA DL... | 41.12 - | 12/31/2078 | Put |
GlobeNewswire
1:30 PM
Buckley Capital Management Urges Dentalcorp Holdings Board and Management to Undertake a Strategic R...
GlobeNewswire
3:00 AM
FASTLY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire
5/28
Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against...
GlobeNewswire
5/28
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Fastly, Inc. (FSLY...
GlobeNewswire
5/28
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fastly...
GlobeNewswire
5/14
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
5/13
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
5/9
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
GlobeNewswire
5/9
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
5/9
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
GlobeNewswire
5/8
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
GlobeNewswire
5/8
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
GlobeNewswire
5/8
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
GlobeNewswire
5/8
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference